Signs and symptoms of VOD poster
This downloadable poster aims to support you and your team in spotting the signs and symptoms of VOD.
Risk assessment and monitoring
ADVERSE EVENTS REPORTING
Adverse events should be reported. Reporting forms and information for the UK can be found at: https://yellowcard.mhra.gov.uk/
For Ireland, reporting forms and information can be found at: www.hpra.ie
Adverse events should also be reported to Jazz Pharmaceuticals at: AEreporting@jazzpharma.com
Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.